Security key
16385C104
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)
CUSIP: 16385C104
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Ordinary Shares / American Depositary Shares
- Total 13F shares
- 2,672,756
- Total 13F value
- $2,441,306
- Share change
- +11,158
- SEC-reported price per share
- $0.91
- Number of holders
- 15
- Value change
- +$15,800
- Number of buys
- 5
- Number of sells
- 5
- Shares outstanding
- 412,914,375
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
15
Top holders
10
CMMB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Chemomab Therapeutics Ltd. SEC filings
Chemomab Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 16385C104
Recent filing periods:
Ownership snapshot
Top reported holders of CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
OrbiMed Israel GP Ltd.
Disclosed value leader
OrbiMed Israel GP Ltd.
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $10,108,146
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
OrbiMed Israel GP Ltd. has the largest disclosed position value at $10.11M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens OrbiMed Israel GP Ltd.'s linked filing trail.
Disclosed position value
Top 5
OrbiMed Israel GP Ltd.
$10.11M
Novo Holdings A/S
$1.95M
ORBIMED ADVISORS LLC
$1.75M
RENAISSANCE TECHNOLOGIES LLC
$452K
VANGUARD GROUP INC
$172.5K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| OrbiMed Israel GP Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$10,108,146
2,241,274 shares
|
— | 03 Jan 2023 |
| Novo Holdings A/S |
13F
Company
|
—
denominator unverified
|
$1,948,277
2,497,791 shares
|
— | 31 Mar 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$1,745,952
2,241,274 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
—
denominator unverified
|
$452,000
578,983 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$172,536
221,200 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
mixed-class rows
|
$171,678
220,070 shares
mixed-class rows
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
2,672,756
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
14
Q2 2024 holders
15
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend